Category: review
-
The FDA has approved alemtuzumab (Lemtrada) as a treatment for patients with multiple sclerosis. The FDA was careful to cite that use of alemtuzumab was a high-risk option since the drug may cause an increased risk for malignancies, including thyroid cancer, melanoma, lymphoproliferative disorders, neuropathy, which in some instances proved fatal. The medication is also marketed as Campath, which…
-
European scientists at the Pain Evaluation and Treatment Centre of Hôpital Ambroise Paré, evaluated several medications for neuropathic pain in an article partially titled “Pharmacotherapy for neuropathic pain in adults”. While research reports and findings are peer-reviewed for scientific correctness, the director of the center, Dr.Nadine Attal, finds certain biases creep into the picture. For…
-
The claims of capsaicin to relieve diabetic neuropathy pain has been reviewed in a recent paper on capsicum (capsaicin) by Krishnapura Srinivasan. Published in the Critical Reviews in Food Science and Nutrition, capsicum, which is the pungent alkaloid of red pepper (Capsicum annuum), has been used for centuries due its pain-relieving abilities. Dr. Srinivasan concluded capsaicin has…
-
A cure for ALS (amyotrophic lateral sclerosis) still seems elusive despite the best efforts of scientists to crack its code. Dr. Martin Turner from the Nuffield Department of Clinical Neurosciences in Oxford, England recently published a paper titled “The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey” in the Journal of Neurology, Neurosurgery and…